Amber received her PhD from the University of Maryland, Baltimore, where studied muscle biology and disease with Dr. Bob Bloch. Her work focused on engineering a xenograft model of the genetically complex muscular dystrophy, FSHD. She went on to pursue a postdoctoral fellowship with Dr. David Sinclair at Harvard Medical School, studying the epigenetic causes and consequences of aging in skeletal muscle, one of the body's most regenerative and metabolically demanding tissues. In addition to muscle biology and aging expertise, Amber has interdisciplinary training in immunology, neuroscience, and bioinformatics. Amber joined the Cell Metabolism team in 2021.
« Go Back